This is the first randomized controlled trial investigating the efficacy and safety of low-dose prolonged methylprednisolone administration in early ARDS. This study tested a pathophysiologic ...
The graft versus host disease market is experiencing significant growth, driven by the ongoing adoption of branded therapies such as JAKAFI, IMBRUVICA, ORENCIA, and REZUROCK compared to off-label ...
All patients were younger than 10 years of age. The patients received either high-dose treatments (0.5–1.0 mg subconjunctival depot, dexamethasone 4 mg/mL, or methylprednisolone acetate 40mg/mL,, and ...
methylprednisolone 1000 mg daily × 3 days followed by high-dose oral glucocorticoids Addition of intravenous 'bolus' cyclophosphamide; use of intravenous γ-globulin; plasma exchange; rituximab?
aDementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK bDepartment of Clinical and Movement Neurosciences, Queen Square Brain Bank for Neurological ...